Home / Companies / Biotechnology & Pharmaceuticals / Novo Nordisk Pharmaceuticals Pty Ltd
Novo Nordisk’s primary business is the development, production, and sale of pharmaceutical products, primarily focused on diabetes care. We maintain a strong commitment to improving the lives of people with diabetes and other chronic diseases. Our portfolio includes insulin, GLP-1 analogs, obesity medications, and other biopharmaceuticals. We also provide services and solutions to support healthcare professionals in the treatment of diabetes and other chronic diseases. Novo Nordisk is dedicated to advancing scientific research and innovation to improve patient outcomes and quality of life.
Source: Great Place To Work® 2024 Australia National Employee Engagement Study
Run the Trust Index™ survey, get Certified™ and your own profile goes live for candidates to find.